Geller Advisors LLC Eli Lilly & CO Transaction History

Geller Advisors LLC

$1.44 Billion
Q3 2024

A detailed history of Geller Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Geller Advisors LLC holds 4,026 shares of LLY stock, worth $2.93 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

4,026

Previous 4,389 8.27%

Holding current value

$2.93 Million

Previous $3.97 Million 10.24%

% of portfolio

0.25%

Previous 0.3%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$772.14 - $960.02 $280,286 - $348,487	-363 Reduced 8.27%	4,026 $3.57 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $142,074 - $178,171	196 Added 4.67%	4,389 $3.97 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $178,252 - $238,476	301 Added 7.73%	4,193 $3.26 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $5,777 - $6,810	-11 Reduced 0.28%	3,892 $2.27 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $290,379 - $400,332	668 Added 20.65%	3,903 $2.1 Million
Q2 2023 Aug 09, 2023	BUY	$350.74 - $468.98 $148,713 - $198,847	424 Added 15.08%	3,235 $1.52 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $166,187 - $195,178	535 Added 23.51%	2,811 $965,000
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $111,899 - $130,385	-348 Reduced 13.26%	2,276 $832,000
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $114,441 - $130,417	386 Added 17.25%	2,624 $848,000
Q2 2022 Aug 10, 2022	SELL	$278.73 - $327.27 $2,229 - $2,618	-8 Reduced 0.36%	2,238 $726,000
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $2,346 - $2,916	10 Added 0.45%	2,246 $643,000
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $15,964 - $19,811	71 Added 3.28%	2,236 $618,000
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $21,273 - $26,180	-96 Reduced 4.25%	2,165 $500,000
Q2 2021 Aug 09, 2021	SELL	$180.55 - $233.54 $17,693 - $22,886	-98 Reduced 4.15%	2,261 $519,000
Q1 2021 May 10, 2021	BUY	$164.32 - $212.72 $119,460 - $154,647	727 Added 44.55%	2,359 $441,000
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $15,353 - $17,758	-105 Reduced 6.04%	1,632 $242,000
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $236,961 - $285,180	1,737 New	1,737 $285,000

Others Institutions Holding LLY

# of Institutions

4,002

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $691B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geller Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geller Advisors LLC with notifications on news.

Account

Geller Advisors LLC Eli Lilly & CO Transaction History